ESC Heart Failure
Scope & Guideline
Innovating the future of heart failure therapies.
Introduction
Aims and Scopes
- Heart Failure Management and Treatment Strategies:
The journal focuses on the latest advancements in heart failure therapies, including pharmacological interventions, device therapies, and surgical approaches. - Epidemiology and Risk Factors:
Research on the epidemiology of heart failure, including prevalence, risk factors, and the impact of comorbidities on heart failure outcomes, is a key focus area. - Diagnostic Innovations:
The journal publishes studies on novel diagnostic techniques and biomarkers that enhance the detection and monitoring of heart failure. - Patient Outcomes and Quality of Life:
There is a strong emphasis on research that evaluates patient-reported outcomes, quality of life, and the psychosocial aspects of living with heart failure. - Multi-disciplinary Approaches:
The journal encourages research that explores multi-disciplinary care models and collaborative strategies in heart failure management. - Advanced Heart Failure and Transplantation:
Articles addressing advanced heart failure, including the use of mechanical circulatory support and heart transplantation, are prominently featured.
Trending and Emerging
- Digital Health and Remote Monitoring:
There is a significant increase in research related to digital health solutions, including telemedicine and remote patient monitoring technologies for managing heart failure. - Artificial Intelligence and Machine Learning:
The utilization of AI and machine learning in predicting heart failure outcomes and personalizing treatment strategies has emerged as a prominent theme. - Heart Failure with Preserved Ejection Fraction (HFpEF):
Research focusing on HFpEF has gained traction, exploring its unique pathophysiology, management strategies, and prognostic indicators. - SGLT2 Inhibitors and Novel Pharmacotherapies:
The growing interest in SGLT2 inhibitors and other novel pharmacotherapies is evident, as studies highlight their benefits in heart failure management. - Psychosocial Factors and Patient-Centered Care:
Increased attention is being paid to psychosocial factors affecting heart failure patients, including mental health, quality of life, and health literacy. - Biomarkers and Precision Medicine:
Emerging research on biomarkers for heart failure diagnosis, prognosis, and treatment response is trending, supporting the movement towards precision medicine.
Declining or Waning
- Traditional Risk Factor Studies:
There has been a noticeable decrease in studies focusing on traditional cardiovascular risk factors (e.g., hypertension, hyperlipidemia) as standalone topics, with more emphasis now on complex interrelations with heart failure. - Single-Center Studies:
The prevalence of single-center studies has decreased as multi-center and large-scale studies are prioritized for their broader applicability and generalizability. - Basic Science and Mechanistic Studies:
Research focusing solely on basic science or mechanistic studies without direct clinical implications has waned, as the journal shifts towards clinically relevant applications. - Historical Data Analysis:
There is a reduced focus on retrospective analyses of historical data, as the field moves toward real-time data and prospective studies that incorporate current treatment paradigms.
Similar Journals
HEART AND VESSELS
Transforming Heart Health Through Scholarly ExcellenceHEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.
JACC-Heart Failure
Elevating Standards in Cardiology ResearchJACC-Heart Failure is a premier journal in the field of cardiology, published by Elsevier Science Ltd, that has rapidly established itself as a vital resource for researchers and practitioners focused on heart failure and cardiovascular health. With an impressive impact factor and ranking in the Q1 category for Cardiology and Cardiovascular Medicine, this journal is recognized for its high-quality peer-reviewed articles that contribute significantly to advancements in clinical practice and scientific understanding of heart failure. As of 2023, the journal ranks #10 out of 387 in its field, positioning it in the 97th percentile of Scopus rankings, which highlights its influential role in disseminating cutting-edge research. Although the journal does not operate under an open-access model, it maintains a rigorous review process, ensuring the publication of articles that are both innovative and clinically relevant. Targeting an audience of dedicated researchers, healthcare professionals, and students, JACC-Heart Failure serves as an essential platform for exploring the complexities of heart failure treatments, management strategies, and future directions in cardiology.
Current Heart Failure Reports
Elevating Standards in Cardiovascular HealthCurrent Heart Failure Reports, published by SpringerNature, is a leading journal dedicated to advancing the field of cardiology, specifically focusing on heart failure. With an impressive impact factor and a recognized reputation, this journal falls under the top quartiles in several categories, including Q1 in Cardiology and Cardiovascular Medicine and Emergency Medicine. Its range of topics encompasses both clinical and research insights into heart failure management, offering valuable perspectives aligned with the latest therapeutic advancements. Although it does not have open access options, researchers and practitioners can find profound studies and reviews aimed at improving patient care and outcomes in cardiovascular health. As the journal converges towards its 20th year in print, it continues to serve as a critical resource for academic professionals, providing a platform for high-quality research that shapes the future of heart failure treatments.
KARDIOLOGIYA
Exploring Innovations in CardiologyKARDIOLOGIYA is a renowned academic journal in the field of cardiology, published by the Russian Heart Failure Society. Since its inception in 1961, this journal has been dedicated to disseminating cutting-edge research in cardiovascular medicine, contributing to the global understanding of heart-related diseases and their management. With a significant publication history that spans over six decades, KARDIOLOGIYA provides a platform for both established researchers and emerging scholars to publish their findings. Despite its current Q4 category ranking in the 2023 Cardiology and Cardiovascular Medicine category, the journal plays a crucial role in promoting regional insights and advancements in cardiology, while striving towards higher visibility and impact within the academic community. While not an open-access journal, the journal is accessible to institutions and professionals in the Russian Federation and beyond, fostering collaboration and knowledge sharing among healthcare professionals. With a Scopus rank of #259 among 387 journals, it is well-positioned to enhance discourse in the field and support the development of innovative approaches to cardiovascular care.
CURRENT CARDIOLOGY REVIEWS
Advancing Cardiovascular Knowledge for Better OutcomesCURRENT CARDIOLOGY REVIEWS, an esteemed journal published by BENTHAM SCIENCE PUBL LTD, is a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1573-403X and E-ISSN of 1875-6557, this journal presents comprehensive reviews that contribute significantly to the advancement of scientific knowledge and clinical practices in cardiology. Operating with open access options, CURRENT CARDIOLOGY REVIEWS is dedicated to bridging the gap between research and practice, thereby encouraging interdisciplinary collaboration and knowledge sharing. The journal has been instrumental in disseminating high-impact findings, consistently maintaining a Q2 category ranking in both Cardiology and Cardiovascular Medicine, as well as within the miscellaneous categories of Medicine, highlighting its relevance and respect in the academic community. Researchers, practitioners, and students alike will find valuable insights into contemporary cardiovascular issues, practices, and innovations that promote better patient outcomes. Based in the United Arab Emirates, CURRENT CARDIOLOGY REVIEWS encourages global contributions and reflects the latest advancements up to the year 2024, solidifying its role as an essential publication for those engaged in the quest for excellence in cardiovascular health.
Cardiology Research and Practice
Empowering the global community with cutting-edge cardiology studies.Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.
AMERICAN JOURNAL OF CARDIOLOGY
Empowering Healthcare Professionals with Cutting-edge InsightsThe American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.
CURRENT OPINION IN CARDIOLOGY
Empowering clinicians with the latest in cardiac research.CURRENT OPINION IN CARDIOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is an esteemed journal in the field of cardiology that has been serving the academic community since 1988. With a robust focus on the latest developments and emerging trends in cardiovascular medicine, this journal aims to bridge the gap between clinical practice and research, offering critical insights and expert commentary. The journal is recognized in the medical community, achieving a 2023 Scopus rank of #148 out of 387 in its category, placing it in the 61st percentile. Although it operates under a subscription-based model, CURRENT OPINION IN CARDIOLOGY remains an essential resource for researchers, practitioners, and students seeking cutting-edge knowledge and advancements in cardiology. As a Q2 journal in the field, it continues to foster dialogue and provide a platform for disseminating impactful cardiovascular research, ultimately contributing to improved patient outcomes and informed clinical decisions.
IJC Heart & Vasculature
Shaping the Future of Cardiovascular Medicine TogetherIJC Heart & Vasculature is a premier open-access journal published by Elsevier Ireland Ltd, dedicated to advancing research in the fields of cardiology and cardiovascular medicine. Since its inception in 2013, this journal has established itself as a valuable resource for clinicians, researchers, and students keen on exploring the latest developments in heart and vascular health. With an impressive impact factor and ranked within Q2 in its category (2023), IJC Heart & Vasculature has achieved a significant Scopus rank of #125 out of 387, placing it in the 67th percentile of cardiology journals. The journal not only emphasizes high-quality research but also promotes innovative studies that can shape clinical practices and improve patient outcomes. Researchers and professionals can access a plethora of peer-reviewed articles, original research, and comprehensive reviews that unravel the complexities of cardiovascular science. With a commitment to fostering open and impactful dialogue in the field, IJC Heart & Vasculature is poised to be an essential platform for knowledge exchange in the evolving landscape of cardiovascular research.
Circulation-Heart Failure
Empowering clinicians with cutting-edge insights.Welcome to Circulation-Heart Failure, a leading peer-reviewed journal published by Lippincott Williams & Wilkins dedicated to advancing the field of cardiac biology and clinical cardiology. With an impressive impact factor and ranked in the Q1 category both in Cardiology and Cardiovascular Medicine and in Medicine (miscellaneous), this journal stands out as a vital resource for researchers, clinicians, and students. Since its inception in 2008, Circulation-Heart Failure has been at the forefront of disseminating innovative research, expert reviews, and clinical practices related to heart failure and cardiovascular health. The journal, housed in the United States, is committed to fostering a deeper understanding of heart failure management, offering regular issues that converge comprehensive studies, cutting-edge clinical insights, and the latest advancements in therapeutic strategies. Engage with the latest findings and contribute to the dialogue in a journal recognized for its rigorous standards and significant contributions to the cardiology community.